| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anthelmintics in the future: current trends in the discovery and development of new drugs against gastrointestinal nematodes
|
Zajíčková, Markéta
|
|
|
25 |
2 |
p. 430-437
|
artikel
|
| 2 |
Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus
|
Black, Labe
|
|
|
25 |
2 |
p. 380-391
|
artikel
|
| 3 |
CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening
|
Chhibber, Tanya
|
|
|
25 |
2 |
p. 456-465
|
artikel
|
| 4 |
Contents page 1
|
|
|
|
25 |
2 |
p. i
|
artikel
|
| 5 |
Contents page 2
|
|
|
|
25 |
2 |
p. ii
|
artikel
|
| 6 |
Continuous progress in continuous manufacturing: on the road to real-time release
|
Cameron, Loe
|
|
|
25 |
2 |
p. 263-264
|
artikel
|
| 7 |
Drugs, discovery, and dermatology: Renbök, research and repurposing
|
Sonthalia, Sidharth
|
|
|
25 |
2 |
p. 259-262
|
artikel
|
| 8 |
Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease
|
Chawla, Sunita
|
|
|
25 |
2 |
p. 392-405
|
artikel
|
| 9 |
Holistic cost-effectiveness analysis of anticancer drug regimens in Japan
|
Teramae, Fumio
|
|
|
25 |
2 |
p. 269-273
|
artikel
|
| 10 |
Horses for courses: an approach to the qualification of clinical trial sites and investigators in ATMPs
|
Hildebrandt, Martin
|
|
|
25 |
2 |
p. 265-268
|
artikel
|
| 11 |
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design
|
Cavalluzzi, Maria Maddalena
|
|
|
25 |
2 |
p. 344-366
|
artikel
|
| 12 |
Key indicators of phase transition for clinical trials through machine learning
|
Feijoo, Felipe
|
|
|
25 |
2 |
p. 414-421
|
artikel
|
| 13 |
New generation drugs for treatment of multiple myeloma
|
Alanazi, Fehaid
|
|
|
25 |
2 |
p. 367-379
|
artikel
|
| 14 |
Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases
|
Sheean, Maria E.
|
|
|
25 |
2 |
p. 274-291
|
artikel
|
| 15 |
Pharmacotherapy for metabolic and cellular stress in degenerative retinal diseases
|
Kubota, Ryo
|
|
|
25 |
2 |
p. 292-304
|
artikel
|
| 16 |
Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications
|
Grimsey, Natasha L.
|
|
|
25 |
2 |
p. 330-343
|
artikel
|
| 17 |
Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies
|
Selmin, Francesca
|
|
|
25 |
2 |
p. 321-329
|
artikel
|
| 18 |
ROCK-2-selective targeting and its therapeutic outcomes
|
Sharma, Prasanti
|
|
|
25 |
2 |
p. 446-455
|
artikel
|
| 19 |
Synthetic lethality: a step forward for personalized medicine in cancer
|
Jariyal, Heena
|
|
|
25 |
2 |
p. 305-320
|
artikel
|
| 20 |
Target discovery using biobanks and human genetics
|
Hicks, Michael A.
|
|
|
25 |
2 |
p. 438-445
|
artikel
|
| 21 |
Targeting CDK2 in cancer: challenges and opportunities for therapy
|
Tadesse, Solomon
|
|
|
25 |
2 |
p. 406-413
|
artikel
|
| 22 |
Targeting heme-oxidized soluble guanylate cyclase to promote osteoblast function
|
Tesfamariam, Belay
|
|
|
25 |
2 |
p. 422-429
|
artikel
|
Tijdschrift beschrijving